MD Anderson Therapeutics Discovery team identifies and advances a drug that targets metabolic vulnerability and impairs cancer cell growth and survival | Newswise: News for Journalists

X

Joseph Marszalek, Ph.D.

Credit: MD Anderson Cancer Center

Joseph Marszalek, Ph.D.

« MD Anderson Therapeutics Discovery team identifies and advances a drug that targets metabolic vulnerability and impairs cancer cell growth and survival

Yonathan Lissanu Deribe, Ph.D.

Credit: MD Anderson Cancer Center

Yonathan Lissanu Deribe, Ph.D.

« MD Anderson Therapeutics Discovery team identifies and advances a drug that targets metabolic vulnerability and impairs cancer cell growth and survival

0.11506